Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iodine-124 Evuzamitide PET/CT Imaging in Carriers of TTR Mutations

NCT07591038 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT07591038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07591038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iodine-124 Evuzamitide PET/CT Imaging in Carriers of TTR Mutations
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
June 30, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attr, attr gene mutation, cardiomyopathy, transthyretin mediated amyloidosis (attr)